![Piet Wigerinck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Piet Wigerinck
Directeur/Membre du Conseil chez
IPSEN
Fortune : 124 266 $ au 31/05/2026
Profil
Actuellement, Piet Wigerinck est Chief Scientific Officer de Galapagos NV. Il est également membre du conseil d'administration d'Ipsen SA et d'Ipsen Pharma SAS. Dans le passé, il a été vice-président de Drug Discovery & Early Development chez Tibotec Pharmaceuticals et vice-président de Drug Discovery & Development Solutions Ltd. Le Dr Wigerinck a obtenu un doctorat de la Katholieke Universiteit Leuven.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IPSEN SA 0 % | 31/12/2025 | 680 ( 0 % ) | 124 266 $ | 31/05/2026 |
Postes actifs de Piet Wigerinck
| Sociétés | Poste | Début |
|---|---|---|
| IPSEN | Directeur/Membre du Conseil | 01/05/2018 |
Antwerp University Hospital
 Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Directeur/Membre du Conseil | - |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Directeur/Membre du Conseil | - |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Directeur/Membre du Conseil | - |
Symeres BV
 Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Directeur/Membre du Conseil | - |
Anciens postes connus de Piet Wigerinck
| Sociétés | Poste | Fin |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur Technique/Scientifique/R&D | 31/12/2021 |
UZA Foundation | Directeur/Membre du Conseil | - |
Xinvento BV
 Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Fondateur | - |
Tibotec Virco Comm. VA
 Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Piet Wigerinck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Antwerp University Hospital
Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Health Services |
Tibotec Virco Comm. VA
Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Commercial Services |
Drug Discovery & Development Solutions Ltd.
 Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Health Technology |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Health Technology |
UZA Foundation |
